Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983;229(3):155-65.
doi: 10.1007/BF00313739.

Clinical parameters and intrathecal IgG synthesis as prognostic features in multiple sclerosis. Part I

Clinical parameters and intrathecal IgG synthesis as prognostic features in multiple sclerosis. Part I

E Verjans et al. J Neurol. 1983.

Abstract

In a search for early prognostic features in multiple sclerosis, the progression rate was calculated in 200 consecutive multiple sclerosis patients who had had a lumbar puncture, and correlated with age at onset, type of disease course, the patient's sex, as well as with indices of blood-brain barrier breakdown and intrathecal IgG synthesis. The present study demonstrates that age at onset plays a role in determining whether the disease will be remitting-relapsing or chronic progressive. Age at onset is also a factor determining the rate of progression of the remitting-relapsing form, but is without influence on the progression of the chronic progressive form. A chronic progressive disease course per se (independent of age at onset) is also associated with a more rapid deterioration. The patient's sex does not appear to be a differentiating factor. Only inconsistent correlations were found between IgG index or number of oligoclonal bands in the CSF and disease progression.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Ann N Y Acad Sci. 1965 Mar 31;122:552-68 - PubMed
    1. J Neurol. 1978 Aug 25;218(4):237-44 - PubMed
    1. Eur Neurol. 1977;15(5):241-8 - PubMed
    1. Neurology. 1968 Mar;18(3):286-7 - PubMed
    1. Immunochemistry. 1965 Sep;2(3):235-54 - PubMed

Substances

LinkOut - more resources